Matthew Everly, PharmD

Matthew Everly, PharmD, has a diverse work experience spanning across multiple industries and roles. Matthew is currently serving as the Senior Director of Global Portfolio Strategy and Evidence Generation at Hansa Biopharma. Prior to this, they held the position of Senior Global Evidence Generation and Solutions Director at the same company.

Before joining Hansa Biopharma, Matthew worked at Takeda Oncology as the Director of Global Evidence & Outcomes. Additionally, they founded and served as the Principal of Cleverly Health LLC.

Matthew has also held academic positions at the University of California, Los Angeles, where they served as an Adjunct Associate Professor of Medicine from 2019 to 2020, and as an Adjunct Assistant Professor of Medicine from 2012 to 2019.

In the field of research, Matthew served as the Institute Director and Chief Executive at the Terasaki Research Institute. Matthew also worked as a Senior Research Scientist at the Terasaki Foundation Laboratory.

Matthew's impressive career also includes the role of Chief Scientific Officer at One Lambda, Inc., now a Thermo Fisher Scientific Brand. Matthew has also worked as a Research Scientist at the Terasaki Research Institute and as the Pharmacy Clinical Coordinator at Mercy Catholic Medical Center.

Earlier in their career, Matthew worked as a Clinical Pharmacist at Penn Medicine, University of Pennsylvania Health System.

Overall, Matthew Everly, PharmD, has built a wealth of experience in pharmaceuticals, research, academia, and leadership throughout their career.

Matthew Everly, PharmD started their education at the University of Cincinnati James L. Winkle College of Pharmacy, where they earned a Bachelor of Pharmacy (BPharm) degree from 1997 to 2001. Matthew then pursued a Doctor of Pharmacy (PharmD) degree from the same institution, completing it from 2000 to 2002.

After obtaining their PharmD, Matthew Everly completed a residency in Transplant Pharmacy at the University of Cincinnati in 2007. In the same year, they also obtained a certification as a Board Certified Pharmacotherapy Specialist (BCPS) from the BPS - Board of Pharmacy Specialties.

Matthew Everly further expanded their knowledge and skills by completing a fellowship in Transplant Clinical Research at the University of Cincinnati in 2008.

In terms of licenses, they are a registered pharmacist in both the State of California and the State of Ohio, maintaining active status for both licenses.